November 9, 2023 | Advisors, DSL advisor, DSL advisory, Digital advisory boards, HCP advisor, HCP advisory, KOL advisor, MSL advisor, MSL advisory, Online advisory board, Virtual advisory boards, WHy are virtual advisory boards, online ad board, virtual ad board
We’re breaking down the benefits of virtual advisory boards, and how they are superior when compared to in-person and hybrid advisory boards.
#6. Far Superior Convenience
Most KOLs have extremely busy work and personal schedules. Even finding a time for a one- or two-hour webinar that works with all advisors’ schedules can be challenging. Accordingly, having the ability to log in and interact with other advisors from anywhere at any time on any device is one of the most important advantages of online advisory boards.
The asynchronous nature of the online touchpoints allows Pharma teams to engage with KOLs in larger geographical areas. There is no longer a need to worry about time zones or language barriers. Non-native English speakers are able to take their time when formulating their responses. They can also leverage automatic language translation features to write and read others’ comments in their preferred language.
To learn more about this and other great benefits of virtual advisory boards, check out our blog https://www.impetusdigital.com/2021/09/17/top-10-benefits-of-virtual-advisory-boards/
Interested in learning how we can help you engage your advisors, HCPs, patients, and stakeholders with expertly executed virtual meetings and programs? Visit us at www.impetusdigital.com or talk to one of our amazing team members via https://meetwithimpetus.com/
Follow us on social media
https://linkedin.com/company/impetus-digital
https://twitter.com/impetus_digital
https://facebook.com/ImpetusDigital.fb
https://impetusdigital.com/podcast/
#AdvisoryBoard #HCP #DOL #KOL #advisors #OnlineAdvisoryBoard #VirtualAdvisoryBoard
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...
Cassie Solomon, CEO of The New Group Consulting, dives into the future of innovation, digital technologies, and systems thinking in healthcare. Among many other things, we discuss how organizations can prepare...
A customer story
Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how...
Kim Shah, CEO of KnowYourMeds, explores digital health, AI, telemedicine, health literacy, and how to ensure a safe return to work amidst the ongoing COVID-19 pandemic. We also dive into...
Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,...
John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical...
Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital...
Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and...
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families.